- £73.55bn
- £86.62bn
- £30.33bn
- 87
- 44
- 99
- 92
REG - GSK PLC - GSK announces positive EAGLE-1 headline results
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - ViiV LAI superior to orals in adherence-challenged
AnnouncementREG - GSK PLC - Julie Brown - External Appointment
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - GSK completes acquisition of Aiolos Bio
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - US FDA Fast Track designation for bepirovirsen
AnnouncementREG - GSK PLC - Shingrix 18+ at risk China filing review accepted
AnnouncementREG - GSK PLC - FDA accepts Arexvy filing for adults 50-59 at risk
AnnouncementREG - GSK PLC - GSK presents positive DREAMM-7 phase III data
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
Announcement